Xinxin Ci

5.0k total citations · 2 hit papers
77 papers, 4.0k citations indexed

About

Xinxin Ci is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinxin Ci has authored 77 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 19 papers in Immunology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinxin Ci's work include Genomics, phytochemicals, and oxidative stress (23 papers), Immune Response and Inflammation (15 papers) and NF-κB Signaling Pathways (11 papers). Xinxin Ci is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (23 papers), Immune Response and Inflammation (15 papers) and NF-κB Signaling Pathways (11 papers). Xinxin Ci collaborates with scholars based in China, United States and Australia. Xinxin Ci's co-authors include Xuming Deng, Qinmei Liu, Hongming Lv, Hongming Lv, Yun Gao, Haihua Feng, Xiaoye Fan, Zhongmei Wen, Liping Peng and Xiao Chu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xinxin Ci

76 papers receiving 4.0k citations

Hit Papers

Xanthohumol ameliorates lipopolysaccharide (LPS)-induced ... 2017 2026 2020 2023 2017 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxin Ci China 37 2.0k 730 672 548 372 77 4.0k
Yunhe Fu China 39 1.6k 0.8× 850 1.2× 435 0.6× 289 0.5× 414 1.1× 89 3.7k
Yue Dai China 43 2.3k 1.1× 706 1.0× 704 1.0× 289 0.5× 400 1.1× 185 5.2k
Tao Wen China 30 2.2k 1.1× 647 0.9× 332 0.5× 378 0.7× 542 1.5× 114 3.8k
Haihua Feng China 40 1.9k 1.0× 540 0.7× 796 1.2× 191 0.3× 253 0.7× 95 4.0k
Tianhua Yan China 32 1.7k 0.8× 463 0.6× 449 0.7× 204 0.4× 281 0.8× 71 3.2k
Soon‐Cheol Ahn South Korea 32 1.5k 0.7× 475 0.7× 307 0.5× 252 0.5× 256 0.7× 127 3.3k
Fermín Sánchez de Medina Spain 41 2.6k 1.3× 556 0.8× 389 0.6× 209 0.4× 280 0.8× 126 5.7k
Carla Cicala Italy 36 1.2k 0.6× 481 0.7× 358 0.5× 299 0.5× 254 0.7× 95 4.3k
Kyung‐Seop Ahn South Korea 31 1.3k 0.6× 576 0.8× 334 0.5× 417 0.8× 163 0.4× 111 3.0k

Countries citing papers authored by Xinxin Ci

Since Specialization
Citations

This map shows the geographic impact of Xinxin Ci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxin Ci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxin Ci more than expected).

Fields of papers citing papers by Xinxin Ci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxin Ci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxin Ci. The network helps show where Xinxin Ci may publish in the future.

Co-authorship network of co-authors of Xinxin Ci

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxin Ci. A scholar is included among the top collaborators of Xinxin Ci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxin Ci. Xinxin Ci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jianqiang, Yan Zhang, Yanmin Zhang, et al.. (2025). Bergenin inhibits ferritinophagy and ferroptosis in cisplatin-induced acute kidney injury by activating the p-GSK3β/Nrf2/PPARγ pathway. International Immunopharmacology. 147. 114004–114004. 5 indexed citations
2.
Tang, Ying, et al.. (2025). Hesperetin alleviates PM2.5-induced lung injury by inhibiting ferroptosis in an Nrf2-dependent manner. International Immunopharmacology. 148. 114123–114123. 2 indexed citations
4.
Hu, Jianqiang, Wenli Hou, Ning Ma, et al.. (2023). Aging-related NOX4-Nrf2 redox imbalance increases susceptibility to cisplatin-induced acute kidney injury by regulating mitophagy. Life Sciences. 336. 122352–122352. 6 indexed citations
5.
Yan, Kun, et al.. (2022). Amentoflavone Ameliorates Carrageenan-Induced Pleurisy and Lung Injury by Inhibiting the NF-κB/STAT3 Pathways via Nrf2 Activation. Frontiers in Pharmacology. 13. 763608–763608. 14 indexed citations
6.
Fan, Xiaoye, et al.. (2022). PM2.5 increases susceptibility to acute exacerbation of COPD via NOX4/Nrf2 redox imbalance-mediated mitophagy. Redox Biology. 59. 102587–102587. 90 indexed citations
7.
Gao, Yun, Xiaoye Fan, Wenjing Gu, Xinxin Ci, & Liping Peng. (2021). Hyperoside relieves particulate matter-induced lung injury by inhibiting AMPK/mTOR-mediated autophagy deregulation. Pharmacological Research. 167. 105561–105561. 32 indexed citations
9.
Wei, Wei, Ning Ma, Xiaoye Fan, Qinlei Yu, & Xinxin Ci. (2020). The role of Nrf2 in acute kidney injury: Novel molecular mechanisms and therapeutic approaches. Free Radical Biology and Medicine. 158. 1–12. 58 indexed citations
10.
Yang, Huahong, Yun Gao, Xiaoye Fan, et al.. (2019). Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells. Frontiers in Oncology. 9. 769–769. 52 indexed citations
11.
Lv, Hongming, Qingfei Xiao, Junfeng Zhou, et al.. (2018). Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity. Frontiers in Pharmacology. 9. 147–147. 70 indexed citations
12.
Lv, Hongming, Qinmei Liu, Junfeng Zhou, et al.. (2017). Daphnetin-mediated Nrf2 antioxidant signaling pathways ameliorate tert-butyl hydroperoxide (t-BHP)-induced mitochondrial dysfunction and cell death. Free Radical Biology and Medicine. 106. 38–52. 99 indexed citations
13.
Wang, Lidong, Songling Zhang, Hang Cheng, et al.. (2016). Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK/Akt/GSK3β pathway. Free Radical Biology and Medicine. 101. 401–412. 117 indexed citations
14.
Chen, Xiaojun, Xiaofeng Yang, Tianjiao Liu, et al.. (2012). Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. International Immunopharmacology. 14(2). 209–216. 149 indexed citations
15.
Zhang, Xiaozhe, Jianhua Li, Chi Chen, et al.. (2010). Protective effect of abamectin on acute lung injury induced by lipopolysaccharide in mice. Fundamental and Clinical Pharmacology. 25(6). 700–707. 22 indexed citations
16.
Ci, Xinxin, Rong Ren, Zhaoyuan Wu, et al.. (2009). Isolation of Two New Prenylflavonols fromEpimedium brevicornumand their Effects on Cytokine Productionin vitro. Planta Medica. 75(8). 843–847. 20 indexed citations
17.
Zhang, Xuemei, Yu Song, Xinxin Ci, et al.. (2008). Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. International Immunopharmacology. 8(7). 982–988. 36 indexed citations
18.
Song, Yu, Xinxin Ci, Na An, et al.. (2008). Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflammation Research. 57(11). 524–529. 133 indexed citations
19.
Ci, Xinxin, Hongyu Li, Yu Song, et al.. (2008). Ceftiofur Regulates LPS-Induced Production of Cytokines and Improves LPS-Induced Survival Rate in Mice. Inflammation. 31(6). 422–427. 9 indexed citations
20.
Ci, Xinxin, Yu Song, Fanqin Zeng, et al.. (2008). Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-κB and MAPK. Biochemical and Biophysical Research Communications. 372(1). 73–77. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026